PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with stable angina.

LV unloading with microaxial flow pumps during complex PCI does not reduce major adverse clinical outcomes in patients with impaired LV function.

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

Emerging evidence may help reshape antiplatelet and lipid strategies for the management of coronary artery disease.

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...

Researchers recently presented data on the secondary endpoints of STEMI-DTU (ST-segment Elevation Myocardial Infarction ...

Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like ...

PRO-TAVI trial shows net clinical benefit compared with PCI before valve replacement ...

Randomised, double-blind, placebo-controlled, multicentre ORBITA-2 trial. 301 participants with stable angina and evidence of ischaemia had antianginal medications withheld for 2 weeks. They were ...

India, April 22 -- AstraZeneca Pharma India Ltd., in collaboration with STEMI India announces the launch of India Coronary Conquest (ICC) 2026, a clinician led, national Complex PCI challenge that ...